Management of acute corneal hydrops secondary to keratoconus with intracameral injection of sulfur hexafluoride (SF6).

Management of acute corneal hydrops secondary to keratoconus with intracameral injection of sulfur hexafluoride (SF6). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Management of acute corneal hydrops secondary to keratoconus with intracameral injection of sulfur hexafluoride (SF6). Abstract Text:

Anita Panda,Anand Aggarwal,Pragati Madhavi,Vijay B Wagh,Tanuj Dada,Abhiyan Kumar,Shalini Mohan,Anita Panda,Anand Aggarwal,Pragati Madhavi,Vijay B Wagh,Tanuj Dada,Abhiyan Kumar,Shalini Mohan,

PURPOSE: To report the use of sulfur hexafluoride (SF6) gas in the management of corneal edema caused by acute corneal hydrops secondary to keratoconus. METHODS: Nine eyes with acute hydrops secondary to keratoconus managed by SF6 gas injected into the anterior chamber (group 1) were compared to another 9 eyes that were managed conservatively with conventional medical therapy (group 2). RESULTS: Of 9 eyes in group 1, 3 had 1 injection, 4 had 2 injections, and the remaining 2 had 3 injections into the anterior chamber. All the eyes in group 1 showed an early resolution of corneal edema at 4 weeks. The same was achieved in group 2 at 12 weeks. The central corneal thickness (CCT) in group 1 and group 2 was >1.0 mm at presentation. The CCT at 3 and 12 weeks in group 1 was 0.99 and 0.65 mm, respectively, whereas CCT in group 2 at 3 weeks was >1.0 mm and at 12 weeks was 0.991 mm (P = 0.001). The mean best spectacle-corrected visual acuity (BSCVA) at 12 weeks in group 1 and group 2 was 0.39 and 0.24, respectively (P = 0.016). The results were significant in favor of group 1 over group 2 both in CCT and BSCVA. CONCLUSION: Early intervention with intracameral SF6 injection is a safe and effective therapy for early reduction of corneal edema in eyes with keratoconus and acute hydrops.

Management of acute corneal hydrops secondary to keratoconus with intracameral injection of sulfur hexafluoride (SF6). Publishing Authors By Initials

A Panda,A Aggarwal,P Madhavi,VB Wagh,T Dada,A Kumar,S Mohan,A Panda,A Aggarwal,P Madhavi,VB Wagh,T Dada,A Kumar,S Mohan,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Management of acute corneal hydrops secondary to keratoconus with intracameral injection of sulfur hexafluoride (SF6). Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cornea

VOLUME: 26

Page Numbers: 1067-9

Journal Abbreviation: Cornea

ISSN: 0277-3740

DAY: 25

MONTH: Oct

YEAR: 2007

Management of acute corneal hydrops secondary to keratoconus with intracameral injection of sulfur hexafluoride (SF6). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8216186

Management of acute corneal hydrops secondary to keratoconus with intracameral injection of sulfur hexafluoride (SF6). Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Management of acute corneal hydrops secondary to keratoconus with intracameral injection of sulfur hexafluoride (SF6). Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Management of acute corneal hydrops secondary to keratoconus with intracameral injection of sulfur hexafluoride (SF6).

AFFILIATION: Cornea, OSD, and Refractive Surgery Service, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India. anitap49@yahoo.com

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cornea

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Management of acute corneal hydrops secondary to keratoconus with intracameral injection of sulfur hexafluoride SF6 Related Publications

• A comparison of brief intervention versus simple advice for alcohol use disorders in a North India community-based sample followed for 3 months.
• A novel patch-field design using an optimized grid filter for passively scattered proton beams.
• Arias-Stella reaction in upper genital tract in pregnant and non-pregnant women: a study of 120 randomly selected cases.
• Association of A1C with cardiovascular disease and metabolic syndrome in Asian Indians with normal glucose tolerance.
• Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy.
• CD19 hyperexpression augments Sle1-induced humoral autoimmunity but not clinical nephritis.
• Cloning and bioinformatics of amphibian mu, delta, kappa, and nociceptin opioid receptors expressed in brain tissue: evidence for opioid receptor divergence in mammals.
• Dietary salt intake and hypertension in an urban south Indian population--[CURES - 53].
• Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.
• Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice.
• Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment.
• Effect of various cooling rates (from 30 degrees C to 5 degrees C) and thawing temperatures on the deep-freezing of Bos Taurus and Bos Bubalis semen.
• Effects of cold shock treatment on angiotensin-converting enzyme activity and on semen characteristics in roosters and bulls.
• Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis.
• Genetic regulation of femoral bone mineral density: complexity of sex effect in chromosome 1 revealed by congenic sublines of mice.
• HSV-1 amplicon-mediated transfer of 128-kb BMP-2 genomic locus stimulates osteoblast differentiation in vitro.
• Haemostatic effects of crystalloid vs colloid prime in patients undergoing coronary artery bypass grafting.
• Identification of mouse Duffy antigen receptor for chemokines (Darc) as a BMD QTL gene.
• Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells.
• Management of acute corneal hydrops secondary to keratoconus with intracameral injection of sulfur hexafluoride (SF6).
• Nuclear factor-E2-related factor-1 mediates ascorbic acid induction of osterix expression via interaction with antioxidant-responsive element in bone cells.
• Osteogenic protein-1 stimulates mRNA levels of BMP-6 and decreases mRNA levels of BMP-2 and -4 in human osteosarcoma cells.
• Oxidized low-density lipoprotein and intimal medial thickness in subjects with glucose intolerance: the Chennai Urban Rural Epidemiology Study-25.
• PI3K/AKT/mTOR hypersignaling in autoimmune lymphoproliferative disease engendered by the epistatic interplay of Sle1b and FASlpr.
• Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo.
• Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer.
• Re: early unreamed intramedullary nailing without a safety interval and simultaneous flap coverage following external fixation in type III B open tibial fractures: a report of four successful cases.
• Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus.
• Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Epinephrine in digital nerve block.
• X-ray Reflectivity Study of Semiconductor Interfaces.